Recent Finacing
Recent Raise
Nemysis develops nutritional therapies for iron deficiency and gluten intolerance, including MRC‑licensed IHAT nano‑iron, E40 glutenase, and a hyaluronic‑acid delivery matrix, pursuing Novel Food and drug pathways.
Focus Areas
Total Raised
Funding round
See the team members at Nemysis.
